# A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

> **NCT04184466** · NA · COMPLETED · sponsor: **Geropharm** · enrollment: 26 (actual)

## Conditions studied

- Clamp Study

## Interventions

- **DRUG:** Insulin Aspart
- **DRUG:** NovoRapid® Penfill®

## Key facts

- **NCT ID:** NCT04184466
- **Lead sponsor:** Geropharm
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-18
- **Primary completion:** 2018-12-19
- **Final completion:** 2018-12-19
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04184466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04184466, "A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04184466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*